Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker. Originally incorporated as West Coast Biologicals, Inc. in California in
Subscribe to see Vaxart, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vaxart, Inc. is a biotech company headquartered in South San Francisco, United States. It is publicly listed (VXRT) with a market capitalisation of $119.6M. Xcout tracks 22 named people at Vaxart, Inc., including Steven Lo (President, Chief Executive Officer & Director).
16 more named people on record for Vaxart, Inc., with roles, board committees and tenure — see the full roster →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.